REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $40,000 | +471.4% | 133,400 | +498.2% | 0.00% | – |
| Q4 2021 | $7,000 | -98.8% | 22,300 | -95.0% | 0.00% | -100.0% |
| Q4 2020 | $606,000 | +201.5% | 449,200 | +52.1% | 0.00% | – |
| Q2 2020 | $201,000 | -15.5% | 295,258 | -42.8% | 0.00% | – |
| Q1 2020 | $238,000 | -44.0% | 516,482 | +8.3% | 0.00% | – |
| Q4 2019 | $425,000 | +45.1% | 476,993 | +17.3% | 0.00% | – |
| Q3 2019 | $293,000 | -32.5% | 406,693 | +17.2% | 0.00% | – |
| Q2 2019 | $434,000 | +54.4% | 346,893 | +25.8% | 0.00% | – |
| Q1 2019 | $281,000 | +88.6% | 275,693 | +72.2% | 0.00% | – |
| Q4 2018 | $149,000 | – | 160,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 5,555,555 | $1,656,000 | 0.43% |
| NEA Management Company, LLC | 14,451,147 | $4,306,000 | 0.12% |
| Sarissa Capital Management LP | 1,851,851 | $552,000 | 0.05% |
| Ikarian Capital, LLC | 1,289,130 | $384,000 | 0.05% |
| FEDERATED HERMES, INC. | 29,048,265 | $8,656,000 | 0.02% |
| WealthTrust Axiom LLC | 68,000 | $20,000 | 0.01% |
| All Terrain Financial Advisors, LLC | 15,000 | $4,000 | 0.00% |
| GYL FINANCIAL SYNERGIES, LLC | 34,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,056 | $37,000 | 0.00% |
| McGuire Investment Group, LLC | 15,000 | $4,000 | 0.00% |